Therapeutic Area | MeSH |
---|---|
nervous system diseases | D009422 |
Brand Name | Status | Last Update |
---|---|---|
ethosuximide | ANDA | 2023-12-27 |
zarontin | ANDA | 2023-07-13 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
absence epilepsy | HP_0011147 | D004832 | G40.A |
epilepsy | EFO_0000474 | D004827 | G40.9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Epilepsy | D004827 | EFO_0000474 | G40.9 | — | — | 1 | 2 | 2 | 5 |
Intellectual disability | D008607 | EFO_0003847 | F73 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | 1 | 1 | — | — | 2 |
Absence epilepsy | D004832 | HP_0011147 | G40.A | — | — | 2 | — | — | 2 |
Ketogenic diet | D055423 | — | — | — | — | 1 | — | — | 1 |
Seizures | D012640 | HP_0002069 | G40.4 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuralgia | D009437 | EFO_0009430 | — | — | 2 | — | — | — | 2 |
Complex regional pain syndromes | D020918 | EFO_1001998 | — | — | 1 | — | — | — | 1 |
Pain | D010146 | EFO_0003843 | R52 | — | 1 | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
Peripheral nervous system diseases | D010523 | HP_0009830 | G64 | — | 1 | — | — | — | 1 |
Migraine disorders | D008881 | EFO_0003821 | G43 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Treatment-resistant depressive disorder | D061218 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Ethosuximide |
INN | ethosuximide |
Description | Ethosuximide is a dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures. It has a role as an anticonvulsant, a geroprotector and a T-type calcium channel blocker. It is a pyrrolidinone and a dicarboximide. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCC1(C)CC(=O)NC1=O |
PDB | — |
CAS-ID | 77-67-8 |
RxCUI | — |
ChEMBL ID | CHEMBL696 |
ChEBI ID | 4887 |
PubChem CID | 3291 |
DrugBank | DB00593 |
UNII ID | 5SEH9X1D1D (ChemIDplus, GSRS) |